Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krista Fischer

Showing results (61-70 of 150) with videos related to

Pageof 15
Sort By:
Plos One|January 21, 2017
MixFit: Methodology for Computing Ancestry-Related Genetic Scores at the Individual Level and Its Application to the Estonian and Finnish Population StudiesToomas Haller, Liis Leitsalu, Krista Fischer, et al.
Aging|January 24, 2022
A catalogue of omics biological ageing clocks reveals substantial commonality and associations with disease riskErin Macdonald-Dunlop, Nele Taba, Lucija Klarić, et al.
The American Journal of Clinical Nutrition|June 5, 2019
Food neophobia associates with poorer dietary quality, metabolic risk factors, and increased disease outcome risk in population-based cohorts in a metabolomics studyHeikki V Sarin, Nele Taba, Krista Fischer, et al.
Neuro Endocrinology Letters|October 24, 2012
Thr136Ile polymorphism of human vesicular monoamine transporter-1 (SLC18A1 gene) influences its transport activity in vitroAhmed M Khalifa, Abena Watson-Siriboe, Sally G Shukry, et al.
International Journal of Epidemiology|February 13, 2014
Cohort Profile: Estonian Biobank of the Estonian Genome Center, University of TartuLiis Leitsalu, Toomas Haller, Tõnu Esko, et al.
Plos One|January 21, 2017
Correction: Methylation Markers of Early-Stage Non-Small Cell Lung CancerKaie Lokk, Tõnu Vooder, Raivo Kolde, et al.
Plos One|July 7, 2012
Methylation markers of early-stage non-small cell lung cancerKaie Lokk, Tõnu Vooder, Raivo Kolde, et al.
Journal of Neuroimmunology|February 11, 2003
Catecholamines in a macrophage cell lineScott W Brown, Randall T Meyers, Karen M Brennan, et al.
BMJ Open|May 27, 2026
Pragmatic trial assessing polygenic risk driven statin therapy for cardiovascular disease prevention: study protocol for the EE-PRS trialAve Voit, Aet Elken, Margus Viigimaa, et al.
European Heart Journal Open|January 5, 2023
Effectiveness and feasibility of cardiovascular disease personalized prevention on high polygenic risk score subjects: a randomized controlled pilot studyMargus Viigimaa, Mikk Jürisson, Heti Pisarev, et al.
Pageof 15

Showing results (61-70 of 150) with videos related to

Sort By:
Pageof 15
Plos One|January 21, 2017
MixFit: Methodology for Computing Ancestry-Related Genetic Scores at the Individual Level and Its Application to the Estonian and Finnish Population StudiesToomas Haller, Liis Leitsalu, Krista Fischer, et al.
Aging|January 24, 2022
A catalogue of omics biological ageing clocks reveals substantial commonality and associations with disease riskErin Macdonald-Dunlop, Nele Taba, Lucija Klarić, et al.
The American Journal of Clinical Nutrition|June 5, 2019
Food neophobia associates with poorer dietary quality, metabolic risk factors, and increased disease outcome risk in population-based cohorts in a metabolomics studyHeikki V Sarin, Nele Taba, Krista Fischer, et al.
Neuro Endocrinology Letters|October 24, 2012
Thr136Ile polymorphism of human vesicular monoamine transporter-1 (SLC18A1 gene) influences its transport activity in vitroAhmed M Khalifa, Abena Watson-Siriboe, Sally G Shukry, et al.
International Journal of Epidemiology|February 13, 2014
Cohort Profile: Estonian Biobank of the Estonian Genome Center, University of TartuLiis Leitsalu, Toomas Haller, Tõnu Esko, et al.
Plos One|January 21, 2017
Correction: Methylation Markers of Early-Stage Non-Small Cell Lung CancerKaie Lokk, Tõnu Vooder, Raivo Kolde, et al.
Plos One|July 7, 2012
Methylation markers of early-stage non-small cell lung cancerKaie Lokk, Tõnu Vooder, Raivo Kolde, et al.
Journal of Neuroimmunology|February 11, 2003
Catecholamines in a macrophage cell lineScott W Brown, Randall T Meyers, Karen M Brennan, et al.
BMJ Open|May 27, 2026
Pragmatic trial assessing polygenic risk driven statin therapy for cardiovascular disease prevention: study protocol for the EE-PRS trialAve Voit, Aet Elken, Margus Viigimaa, et al.
European Heart Journal Open|January 5, 2023
Effectiveness and feasibility of cardiovascular disease personalized prevention on high polygenic risk score subjects: a randomized controlled pilot studyMargus Viigimaa, Mikk Jürisson, Heti Pisarev, et al.
Pageof 15